Clinical Trial Update: Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial compares maintenance therapy with gefitinib plus pemetrexed versus pemetrexed alone in stage IV non-small cell lung cancer pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: NSCLC | Phase 2, Phase 3 | Status: UNKNOWN